UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Identification, recombinant expression, and characterization of the 100 kDa high molecular weight Hymenoptera venom allergens Api m 5 and Ves v 3

The Journal of immunology (1950), 2010-05, Vol.184 (9), p.5403-5413

2010

Volltextzugriff (PDF)

Identification of Hymenoptera venom–allergic patients with negative specific IgE to venom extract by using recombinant allergens

Journal of allergy and clinical immunology, 2014-03, Vol.133 (3), p.909-910

2014

Volltextzugriff (PDF)

Thermosensitive PLGA–PEG–PLGA Hydrogel as Depot Matrix for Allergen-Specific Immunotherapy

Pharmaceutics, 2022-07, Vol.14 (8), p.1527

2022

Volltextzugriff (PDF)

Recombinant phospholipase A1 (Ves v 1) from yellow jacket venom for improved diagnosis of hymenoptera venom hypersensitivity

Clinical and molecular allergy CMA, 2010-04, Vol.8 (1), p.7-7, Article 7

2010

Volltextzugriff (PDF)

Comparative Analysis of the Human and Chicken Prion Protein Copper Binding Regions at pH 6.5

The Journal of biological chemistry, 2005-04, Vol.280 (14), p.13987-13992

2005

Volltextzugriff (PDF)

Molecular cloning and expression in insect cells of honeybee venom allergen acid phosphatase (Api m 3)

Journal of Allergy and Clinical Immunology, 2006-04, Vol.117 (4), p.848-854

2006

Volltextzugriff (PDF)

Complement Inactivation by Recombinant Human C3 Derivatives

The Journal of immunology (1950), 2004-11, Vol.173 (9), p.5540-5545

2004

Volltextzugriff (PDF)

A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma : Growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin m antibodies

Cancer research (Chicago, Ill.), 2001-04, Vol.61 (7), p.2968-2973

2001

Volltextzugriff (PDF)

Normal Human Serum Contains a Natural IgM Antibody Cytotoxic for Human Neuroblastoma Cells

Proceedings of the National Academy of Sciences - PNAS, 1996-04, Vol.93 (9), p.4498-4503

1996

Volltextzugriff (PDF)

Molecular Cloning and Derived Primary Structure of Cobra Venom Factor

Proceedings of the National Academy of Sciences - PNAS, 1994-12, Vol.91 (26), p.12775-12779

1994

Volltextzugriff (PDF)

Classical complement pathway activation on nucleated cells. Role of factor H in the control of deposited C3b

The Journal of immunology (1950), 1995-11, Vol.155 (10), p.4955-4962

1995

Volltextzugriff (PDF)

Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps

The Journal of immunology (1950), 1994-09, Vol.153 (5), p.2213-2221

1994

Volltextzugriff (PDF)

N-linked oligosaccharides of cobra venom factor contain novel (1-3)galactosylated Lex structures

Glycobiology (Oxford), 2001-03, Vol.11 (3), p.195-208

2001

Volltextzugriff (PDF)

Primary structure of cobra complement component C3

The Journal of immunology (1950), 1992-12, Vol.149 (11), p.3554-3562

1992

Volltextzugriff (PDF)

Immunoreactivity and function of oligosaccharides in cobra venom factor

The Journal of immunology (1950), 1994-03, Vol.152 (6), p.2977-2986

1994

Volltextzugriff (PDF)

Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen

Cancer research (Chicago, Ill.), 1999-08, Vol.59 (15), p.3768-3775

1999

Volltextzugriff (PDF)

Corrections: Molecular Cloning and Derived Primary Structure of Cobra Venom Factor

Proceedings of the National Academy of Sciences - PNAS, 1995-08, Vol.92 (16), p.7605-7605

1995

Volltextzugriff (PDF)

C3-cleaving membrane proteinase. A new complement regulatory protein of human melanoma cells

The Journal of immunology (1950), 1990-05, Vol.144 (10), p.3862-3867

1990

Volltextzugriff (PDF)

Delivery of radionuclides to pretargeted monoclonal antibodies using dihydrofolate reductase and methotrexate in an affinity system

Cancer research (Chicago, Ill.), 1993-05, Vol.53 (10), p.2368-2373

1993

Volltextzugriff (PDF)

Correction to Abstract 8.09 from the Twenty-First Annual Meeting of the Society for Complex Carbohydrates

Glycobiology (Oxford), 1993-06, Vol.3 (3), p.192-192

1993

Volltextzugriff (PDF)

Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65

Cancer research (Chicago, Ill.), 1993-02, Vol.53 (3), p.592-599

1993

Volltextzugriff (PDF)

Resistance of human melanoma cells against the cytotoxic and complement-enhancing activities of doxorubicin

Cancer research (Chicago, Ill.), 1987-09, Vol.47 (17), p.4601-4607

1987

Volltextzugriff (PDF)

Immobilized Doxorubicin Increases the Complement Susceptibility of Human Melanoma Cells by Protecting Complement Component C3b against Inactivation

Proceedings of the National Academy of Sciences - PNAS, 1986-12, Vol.83 (23), p.9144-9148

1986

Volltextzugriff (PDF)

Quantitation of coronary venous adenosine in patients: limitations evaluated by radioimmunoassay

Cardiovascular research, 1988-04, Vol.22 (4), p.236-243

1988

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

ThemaChemistry

KollektionEZB Electronic Journals Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Humans
(17)
Life Sciences & Biomedicine
(16)
Animals
(11)
Biological And Medical Sciences
(9)
Immunology
(9)
Medical Sciences
(7)
Molecular Sequence Data
(5)
Tumor Cells, Cultured
(5)
Allergy
(4)
Antigens
(4)
Cell Line
(4)
Complement C3 - Metabolism
(4)
Fundamental And Applied Biological Sciences. Psychology
(4)
Fundamental Immunology
(4)
Oncology
(4)
Allergies
(3)
Amino Acid Sequence
(3)
Antibodies
(3)
Antigens, Neoplasm - Immunology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identification, recombinant expression, and characterization of the 100 kDa high molecular weight Hymenoptera venom allergens Api m 5 and Ves v 3

Identification of Hymenoptera venom–allergic patients with negative specific IgE to venom extract by using recombinant allergens

Thermosensitive PLGA–PEG–PLGA Hydrogel as Depot Matrix for Allergen-Specific Immunotherapy

Recombinant phospholipase A1 (Ves v 1) from yellow jacket venom for improved diagnosis of hymenoptera venom hypersensitivity

Comparative Analysis of the Human and Chicken Prion Protein Copper Binding Regions at pH 6.5

Molecular cloning and expression in insect cells of honeybee venom allergen acid phosphatase (Api m 3)

Complement Inactivation by Recombinant Human C3 Derivatives

A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma : Growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin m antibodies

Normal Human Serum Contains a Natural IgM Antibody Cytotoxic for Human Neuroblastoma Cells

Molecular Cloning and Derived Primary Structure of Cobra Venom Factor

Classical complement pathway activation on nucleated cells. Role of factor H in the control of deposited C3b

Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps

N-linked oligosaccharides of cobra venom factor contain novel (1-3)galactosylated Lex structures

Primary structure of cobra complement component C3

Immunoreactivity and function of oligosaccharides in cobra venom factor

Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen

Corrections: Molecular Cloning and Derived Primary Structure of Cobra Venom Factor

C3-cleaving membrane proteinase. A new complement regulatory protein of human melanoma cells

Delivery of radionuclides to pretargeted monoclonal antibodies using dihydrofolate reductase and methotrexate in an affinity system

Correction to Abstract 8.09 from the Twenty-First Annual Meeting of the Society for Complex Carbohydrates

Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65

Resistance of human melanoma cells against the cytotoxic and complement-enhancing activities of doxorubicin

Immobilized Doxorubicin Increases the Complement Susceptibility of Human Melanoma Cells by Protecting Complement Component C3b against Inactivation

Quantitation of coronary venous adenosine in patients: limitations evaluated by radioimmunoassay

Aktive Filter

Suchergebnisse filtern